Market Overview
The Global pharmaceutical visual inspection systems market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Pharmaceutical visual inspection aims to determine the absence or presence of visible particles within products. An inspection machine is mostly helpful to the pharmaceutical sector. It has numerous other applications in the nutraceutical and nutritional supplement industries. It works well as a capsule sorting device that removes flawed capsules. Typically, this kind of gadget uses little electricity and requires little upkeep.
Especially during formulation development, where visual inspection is mainly used to detect proteinaceous particles, a ranking of the extent of visible particle formation can be beneficial to differentiate between formulations with only a few visible particles and those with a high number of visible particles. During formulation development, a visual inspection is performed to judge if particles are formed within formulations. For this application, usually a small number of vials/containers is inspected and a rating of the extent of visible particle formation can be helpful to differentiate between formulations.
Market Scope
| Metrics | Details |
| CAGR | Prominent Growth |
| Market Size | 2022-2031 |
| Market Estimation Forecast Period | 2024-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Machine Type, Technology, Application, End-User |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
To know more Insights - Request for Sample
Market Dynamics: Drivers
Increasing demand for advanced machines
The increasing demand for advanced visual inspection machines is expected to drive the market over the forecast period. Technical development is an ongoing process and machine vision inspection systems are not a novelty but a necessity. Constantly changing factory automation and the need to adhere to newer standards of quality parameters make it necessary for manufacturers to use advanced machine vision in their production processes.
For instance, on July 25, 2023, Norwalt launched its new bottle vision inspection system, the Vue Inspection System. Designed in the company’s Vision Systems Lab, the new product aims to integrate standardized vision components with custom-made elements and deep learning tools. Norwalt conceptualized, designed and engineered the Vue Inspection System in its Vision Systems Lab.
The facility incorporates visual inspection and deep learning tools, including artificial intelligence (AI) vision innovations and 3D profiling. The custom automation and line integration machinery manufacturer also integrates optical character recognition (OCR) and verification via optical character verification (OCV) at its lab.
Advanced visual inspection systems use cutting-edge technologies such as high-resolution cameras, machine learning algorithms and computer vision to detect even minute defects in pharmaceutical products. This level of precision is challenging to achieve through manual inspection and contributes to a higher level of product quality.
For instance, on October 12, 2022, the Antares Vision Group launched a new automatic visual inspection system that guarantees 100% quality inspections of pre-filled (PFS) syringes. The VRI-VI 060 S series detects particles, cosmetics and filling level defects.
Further, the increasing adoption of various types of visual inspection machines for various pharmaceutical applications, enhanced machine reputation, enhanced data quality, accurate results and enhanced productivity and increasing technological advancements are the factors expected to drive the market over the forecast period.
Restraints
Factors such as high cost associated with the visual inspection systems, lack of skilled professionals, complications associated with the visual inspection machines and these machines are only able to detect large flaws are expected to hamper the market.
Market Segment Analysis
The global pharmaceutical visual inspection systems market is segmented based on machine type, technology, application, end-user and region.
The automatic machines segment accounted for approximately 48.4% of the pharmaceutical visual inspection systems market share
The automatic visual inspection machines segment is expected to hold the largest market share over the forecast period. Automatic inspection systems using machine vision significantly reduce wastage thereby improving the ROI. Defects are caught early in the production cycle and do not penetrate through, significantly reducing wastage. Additionally, it prevents recalls or returns of defective products, which enhances customer satisfaction and reduces extra shipping costs.
Automatic visual inspection machines operate at high speeds, allowing for rapid inspection of a large number of products within a short timeframe. This is particularly beneficial in industries with high production volumes. These types of machines also use AI technology to yield high accuracy and better inspection and defect detection of the pharmaceutical products.
For instance, on February 23, 2021, Stevanato Group launched an AI platform that reportedly leverages the benefits of human-like decision-making in automatic visual inspection equipment. The platform is designed to allow pharma companies to overcome the traditional trade-off between detection rate and false rejection rate. The product reportedly yields up to 99.9% accuracy, both for particle inspection and cosmetic defects detection.
Automation ensures a high level of consistency in inspection processes. These machines are programmed to follow specific parameters precisely, reducing the likelihood of errors and variations that may occur with manual inspection. Automatic visual inspection machines are equipped with advanced imaging technologies, such as high-resolution cameras and precision sensors. This enables them to detect subtle and microscopic defects that may be challenging for human inspectors to identify.
For instance, on February 03, 2021, Syntegon Technology installed the first fully validated visual inspection system utilizing Artificial Intelligence (AI) in an automated inspection machine. The installation constitutes a major step in the company’s sustained effort to introduce AI to pharmaceutical visual inspection, thereby exploring largely uncharted territory in the industry.
Market Geographical Share
North America accounted for approximately 42.5% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing technological advancements. North America especially the United States is known for its strong presence of major players such as pharmaceutical companies and medical device companies that play a very crucial role visual inspection systems market. The strong presence of major players mainly focuses on technological advancements like Artificial Intelligence (AI) technology for more precise inspections.
For instance, on May 28, 2024, ACIC Pharmaceuticals Inc. launched a cutting-edge robotic visual inspection machine for Ready-To-Use (RTU) containers. This state-of-the-art system employs advanced camera technology and Artificial Intelligence (AI) to deliver precise inspections for particulate matter and cosmetic defects. The machine can inspect different types of containers – such as vials, syringes, and cartridges – with varying sizes and shapes, and has a speed range of 6 to 20 BpM.
Market Companies
The major global players in the pharmaceutical visual inspection systems market include Daiichi Jitsugyo Asia Pte. Ltd., Stevanato Group, Syntegon Technology GmbH, Sensum d.o.o., Yenchen Machinery Co., Ltd., United Pharmatek USA, Key International, Inc., Meliscout GmbH, BREVETTI CEA S.P.A, and SaintyCo among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global pharmaceutical visual inspection systems market. The focus of pharmaceutical companies shifted toward the production of essential drugs and vaccines to address the immediate needs of the pandemic. This may have influenced investment decisions and priorities, potentially impacting the adoption of visual inspection systems for COVID-19-related pharmaceuticals like COVID-19 vaccines. For instance, the inspection machines from Syntegon are used in the production of the novel mRNA Covid-19 vaccines.
Why Purchase the Report?
- To visualize the global pharmaceutical visual inspection systems market segmentation based on machine type, technology, application, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of pharmaceutical visual inspection systems market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global pharmaceutical visual inspection systems market report would provide approximately 69 tables, 73 figures and 189 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
